跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tecentriq - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tecentriq
Approved
STANDARD
Tecentriq
F. Hoffmann-La Roche AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
16870a680a192be9
Company
F. Hoffmann-La Roche AG
Type
Standard
Approval Details
Approval Id
16870a680a192be9
Drug Approval Philippines Name
Tecentriq
Product Name
Tecentriq
Registration Number
BR-1436
Brand Name
Tecentriq
Generic Name
Atezolizumab
Dosage Form
Concentrate for Solution for Infusion (IV)
Dosage Strength
1200 mg/20 mL (60 mg/mL)
Manufacturer
F. Hoffmann-La Roche AG
Trader
F. Hoffmann-La Roche Ltd.
Importer
Roche (Philippines), Inc.
Distributor
Roche (Philippines), Inc.
Company Detail Path
/organization/f-hoffmann-la-roche-ag
Trader Detail Path
/organization/f-hoffmann-la-roche-ltd-switzerland
Issuance Date
11 January 2023
Expiry Date
11 January 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
16870a680a192be9
Type
Standard
Back to Philippines FDA Approvals